WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 15'1801 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 19'5901 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 3'407  3'395  3'383  3'372  3'360  3'321  3'110  2'916 
Births 49  49  50  50  50  54  57  56 
Surviving infants 49  49  49  49  49  53  56  54 
Pop. less than 5 years 244  245  246  247  248  271  271  277 
Pop. less than 15 years 744  749  754  759  765  815  809  785 
Female 15-49 years 821  819  817  815  813  806  743  696 

Number of reported case

(Click for retrospective incidence data for Uruguay)
Diphtheria
Japanese encephalitis
Measles 110  141 
Mumps 204  113  132  169  256  20 
Pertussis 320  598  639  36  161  192 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uruguay)
Vaccine year result method % card seen                                                
BCG          98  99  99  99  99  99  99  56 
DTP1          98  98  99  98  98  92 
DTP3          95  95  95  95  95  90  97  53 
HepB_BD         
HepB3          95  95  95  95  95  92 
Hib3          95  95  95  95  95  88 
JapEnc         
MCV          96  96  95  95  95  89  97  50 
MCV2          92 
PCV1          96  97  99  99  70 
PCV3          93  93  92  91 
Pol3          95  95  95  95  95  92  97  59 
Rota1         
Rota_last         
Rubella1          96  96  95  95  95 
TT2plus          18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uruguay)
BCG 98  99  99  99  99  99  99  56 
DTP1 98  98  99  98  99  92  98  77 
DTP3 94  95  95  95  95  90  97  53 
HepB3 94  95  95  95  95  92 
HepB_BD
Hib3 94  95  95  95  95  88 
MCV 96  96  95  95  94  89  97  50 
MCV2 92 
PCV3 93  93  92  91 
Pol3 94  95  95  95  95  92  97  59 
Rota_last

Number of districts in the country 275  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 1
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 15 months; Yes contra-indication to pertussis
DTwP 5 years; Yes
DTwPHibHep 2, 4, 6, 15 months; Yes
HIB 2, 4, 6, 15 months; Yes contra- indication to pertussis
HPV 12 years (x3);
HepA 15, 21 months; Yes
HepB 2, 4, 6, 15 months; Yes Contra-indication to pertussis
IPV 2, 4, 6, 15 months; Yes
Influenza 6 months to 4 years; Yes risk groups, HCW and PW
MMR 1, 5 years; Yes
Pneumo_conj 2, 4 months; 1 year; Yes
Pneumo_ps > =65 years; Yes and risk groups
Td 22 years; Yes
Tdap 12 years; Yes
Varicella 1 year; Yes
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2015  2010-2015  2009-2010  2008-2009  2003-2007 
Nº of districts with microplans that include activities to raise immunization coverage number       275    NA   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 275  275  275  275  275  275  275 
Nº districts with DTP3 coverage >=80% number 278  275  275  275  275  275 
% of districts with DTP3 coverage >=80% From 0 to 100% 101  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 268  264  253  250  256  256   
% of districts with MCV1 coverage >=95% From 0 to 100% 97  96  92  91  93  93   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100    100  100    100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.